[HTML][HTML] The steps to therapeutic drug monitoring: a structured approach illustrated with imatinib

T Buclin, Y Thoma, N Widmer, P André… - Frontiers in …, 2020 - frontiersin.org
Pharmacometric methods have hugely benefited from progress in analytical and computer
sciences during the past decades, and play nowadays a central role in the clinical …

Development and implementation of electronic health record–integrated model‐informed clinical decision support tools for the precision dosing of drugs

AA Vinks, RW Peck, M Neely… - Clinical Pharmacology & …, 2020 - Wiley Online Library
Imagine it is 2030, and the drug label is in the cloud, is interactive, and can provide model‐
informed precision dosing support based on an individual's genomic and physiologic …

[HTML][HTML] Model-informed precision dosing of vancomycin in hospitalized children: implementation and adoption at an academic children's hospital

A Frymoyer, HT Schwenk, Y Zorn, L Bio… - Frontiers in …, 2020 - frontiersin.org
Background Model-informed precision dosing (MIPD) can serve as a powerful tool during
therapeutic drug monitoring (TDM) to help individualize dosing in populations with large …

MTXPK. org: a clinical decision support tool evaluating high‐dose methotrexate pharmacokinetics to inform post‐infusion care and use of glucarpidase

ZL Taylor, T Mizuno, NC Punt… - Clinical …, 2020 - Wiley Online Library
Methotrexate (MTX), an antifolate, is administered at high doses to treat malignancies in
children and adults. However, there is considerable interpatient variability in clearance of …

Population pharmacokinetic study of tacrolimus in pediatric patients with primary nephrotic syndrome: A comparison of linear and nonlinear Michaelis–Menten …

L Huang, Y Liu, Z Jiao, J Wang, L Fang… - European Journal of …, 2020 - Elsevier
Background Little is known about the population pharmacokinetics (PPK) of tacrolimus
(TAC) in pediatric patients with primary nephrotic syndrome (PNS). In this study, we aimed to …

Monoclonal antibody monitoring: clinically relevant aspects, a systematic critical review

M Regazzi, J Golay, M Molinaro - Therapeutic Drug Monitoring, 2020 - journals.lww.com
Monoclonal antibody (mAb) therapy does not usually lead to a clinical response in all
patients and resistance may increase over time after repeated mAb administration. This lack …

Real-time online probabilistic medical computation using bayesian networks

S Mclachlan, H Paterson, K Dube… - 2020 IEEE …, 2020 - ieeexplore.ieee.org
Advances in both computing power and novel Bayesian inference algorithms have enabled
Bayesian Networks (BN) to be applied for decision-support in healthcare and other domains …

Area under the curve achievement of once daily tobramycin in children with cystic fibrosis during clinical care

JM Brockmeyer, RT Wise, EB Burgener… - Pediatric …, 2020 - Wiley Online Library
Background The area under the concentration‐time curve over 24 hours (AUC24) is
frequently utilized to monitor tobramycin exposure in children with cystic fibrosis (CF). An …

基于最大后验贝叶斯法的个体化用药研究进展

周尔君, 潘雁, 朱敏, 刘晓芹, 焦正 - 药学进展, 2020 - pps.cpu.edu.cn
最大后验贝叶斯法(MAPB) 在个体化给药中的作用日益受到重视. 该法通过已知的目标人群的
群体药动学(PPK) 特征, 结合治疗药物监测(TDM) 结果, 可准确地估算患者个体药动学(PK) 参数 …

External validation of the predictive performance of population pharmacokinetic models for phenobarbital in pediatric patients

S Ryu, WJ Jung, Z Jiao, JW Chae, H Yun - medRxiv, 2020 - medrxiv.org
Aim Several studies have reported population pharmacokinetic models for phenobarbital
(PB), but the predictive performance of these models has not been well documented. This …